领航医药生物科技(00399) - 2025 - 中期财报

Other Information Provided AUDIT COMMITTEE DIRECTORS' SECURITIES The Company has adopted the Model Code for Securities Transactions by Directors of Listed Issuers (the "Model Code") as set out in Appendix 10 to the Listing Rules as the code of conduct regarding Directors' securities transactions. Upon specific enquiries being made with all the Directors, each of them have confirmed that they have fully complied with the required standards set out in the Model Code throughout the Financial Period in relation ...